Stage I carcinoma of the endometrium: a 5-year experience utilizing preoperative cesium.
A treatment protocol for the management of stage I endometrial carcinoma utilizing preoperative cesium is evaluated. One hundred and twelve consecutive patients were treated according to this protocol over a 5-year period. Based on this experience and a literature review a new protocol is recommended. The significant changes include primary surgery without preoperative cesium, primary treatment based on grade without regard to uterine size, modified radical hysterectomy for G3 tumors, pelvic radiotherapy for clear cell carcinoma confined to the pelvis regardless of depth of invasion, cytoxan, adriamycin, and cis-platinum for papillary serous tumors, and postoperative vaginal cuff cesium for G2 and G3 tumors not requiring pelvic radiotherapy.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001918:Brachytherapy; D002586:Cesium / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008197:Lymph Node Excision; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D010388:Pelvis / Q000528:radiation effects; D011300:Preoperative Care; D011379:Prognosis; D011879:Radiotherapy Dosage; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery
D000970:Antineoplastic Agents; D002586:Cesium